Needles for Allergy Shots: Why They're Used and Needle-Free Options
Needles are required specifically for subcutaneous immunotherapy (SCIT) — but not for all forms of allergen immunotherapy. FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek, Odactra) and off-label sublingual drops work through the same allergen-specific tolerance mechanism with no needle. The SCIT needle is a 26G or 27G × ½-inch tuberculin syringe per Cox 2011 PP3. Biologics like Xolair use needles but are NOT immunotherapy.
6 peer-reviewed sources
Needles are required for SCIT specifically — the subcutaneous route defines the treatment. However, FDA-approved SLIT tablets and off-label sublingual drops achieve the same allergen-specific tolerance mechanism without any needle.
The essentials
When patients ask whether they need a needle for allergy shots, the honest answer is: it depends on which type of allergen immunotherapy. For subcutaneous immunotherapy (SCIT) — the classic allergy shot — yes, a needle is the defining delivery device. SCIT is by definition subcutaneous: the allergen is injected below the skin using a 26G or 27G × ½-inch needle on a 1 mL tuberculin syringe per Cox 2011 PP3. The subcutaneous route is not arbitrary — it delivers allergen to dendritic cells in the fat layer and dermis at a pharmacologically favorable rate for immune tolerance induction.
Curex pairs at-home IgE testing with allergist review to identify the specific allergens driving symptoms — the molecular workup that determines whether needle-based SCIT or needle-free sublingual immunotherapy is the better fit.
For allergen immunotherapy more broadly, needles are not mandatory. The following needle-free options exist:
FDA-approved SLIT tablets: Grastek (Timothy grass, ages 5–65), Oralair (five grass pollens, ages 5–65), Ragwitek (short ragweed, age 5+), and Odactra (house dust mite, ages 5–65 per Feb 2025 label revision). These are taken daily under the tongue. All carry boxed warnings for anaphylaxis and severe laryngopharyngeal reactions, require a supervised first dose in a clinical setting, and require an epinephrine auto-injector prescription.
Off-label SLIT drops: compounded liquid allergen immunotherapy taken under the tongue daily. Not FDA-approved as finished products but used widely in the US. Cochrane-grade evidence exists for grass, house dust mite, and ragweed indications (Calderón et al., Lin SY et al.).
Biologics should not be confused with immunotherapy: Xolair (omalizumab), Dupixent (dupilumab), and Tezspire (tezepelumab) all involve subcutaneous injections, but they treat allergic diseases via anti-IgE, anti-IL-4/13, and anti-TSLP mechanisms respectively — they do not induce allergen-specific tolerance and are not interchangeable with SCIT or SLIT.
For patients who want to keep the needle-based SCIT protocol but skip the weekly clinic trips, Curex offers the At-Home Allergy Shot Kit — a personalized SCIT serum, sterile-compounded to USP <797>, self-administered as one weekly subcutaneous shot at home for $129/month. Safety is built into the program: a board-certified allergist oversees the plan, a prescribed epinephrine auto-injector is confirmed on hand before the first injection, and the first dose plus every dose escalation are supervised live over Zoom by the care team.
How allergy shots retrain your immune system
SCIT's needle delivers allergen to subcutaneous dendritic cells for slow, tolerogenic uptake. SLIT's dissolving tablet or liquid drop delivers allergen to sublingual Langerhans-like dendritic cells that are constitutively pre-programmed toward tolerance. Both pathways converge on the same immune outcome: regulatory T-cell expansion, IgG4 blocking antibody production, and progressive mast cell desensitization over 3–5 years per Cox 2011. The needle is a feature of the subcutaneous route — not a requirement of allergen immunotherapy as a category.
Why SCIT Uses a Needle
Subcutaneous delivery places allergen in the fat layer for uptake by dermal myeloid dendritic cells at a slow, tolerogenic rate. The 26G–27G × ½-inch needle targets this specific anatomical depth. Intramuscular or intradermal delivery changes the absorption kinetics and safety profile.
FDA-Approved Needle-Free: SLIT Tablets
Grastek (Timothy grass, 5–65 yr), Oralair (5 grasses, 5–65 yr), Ragwitek (short ragweed, 5+), Odactra (dust mite, 5–65 yr). Daily sublingual tablet. Supervised first dose in clinic. Epinephrine auto-injector required. Boxed warning for severe reactions.
Off-Label Needle-Free: SLIT Drops
Compounded sublingual liquid drops, not FDA-approved as finished products. Used widely in the US for multi-allergen indications. Same 3–5 year commitment as SCIT. Cochrane-grade evidence for grass, dust mite, ragweed. No in-clinic observation required.
Biologics — Needles But Not Immunotherapy
Xolair (omalizumab), Dupixent (dupilumab), Tezspire (tezepelumab) are subcutaneous injections but NOT allergen-specific immunotherapy. They modify inflammatory pathways without inducing allergen-specific tolerance. A different product class — not a substitute for SCIT or SLIT.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Do you have to use needles for allergy immunotherapy?
No — needles are required for subcutaneous immunotherapy (SCIT) specifically, but not for allergen immunotherapy as a category. FDA-approved sublingual immunotherapy tablets (Grastek for Timothy grass, Oralair for five grasses, Ragwitek for short ragweed, Odactra for house dust mite) are taken daily under the tongue with no needle. Off-label sublingual drops are also used widely for multi-allergen indications. Both SLIT options engage the same allergen-specific tolerance mechanism as SCIT — regulatory T-cell expansion and IgG4 blocking antibody production — via oral mucosal dendritic cells rather than subcutaneous dermal dendritic cells. The 3–5 year duration commitment is the same for both routes.
What is the needle used for allergy shots?
Per Cox 2011 PP3 and ACAAI administration guidance, the standard allergy shot needle is 26G or 27G gauge, ½-inch in length, mounted on a 1 mL tuberculin syringe. Some protocols use a 27G × ⅜-inch needle. The 26G–27G gauge is finer than a typical flu shot needle (22G–23G), and the ½-inch length ensures subcutaneous — not intramuscular — delivery. Dose volumes range from 0.05 mL at the start of build-up to 0.5 mL at maintenance. The syringe graduations are in 0.01 mL increments, enabling precise volume delivery across the full escalation range.
Is SLIT as effective as SCIT for allergy shots?
Network meta-analyses comparing SLIT and SCIT head-to-head show comparable clinical outcomes for the best-studied allergens: grass pollen and house dust mite. Nelson et al. (JACI In Practice 2015) found no statistically significant difference in symptom reduction between SLIT and SCIT for grass-sensitized patients. SLIT requires 50–100 times higher allergen doses per session to achieve equivalent efficacy to SCIT; this dose difference is why SLIT can be self-administered daily at home without the systemic-reaction risk that mandates 30-minute in-clinic observation for SCIT. For allergens with stronger SCIT evidence (cat, ragweed, Hymenoptera venom), SCIT data remain more robust. For patients prioritizing convenience and avoidance of the needle, SLIT's evidence base for grass and dust mite is Cochrane-grade.
Are Xolair and allergy shots the same thing?
No. Xolair (omalizumab) and allergy shots are entirely different treatments. Xolair is an anti-IgE monoclonal antibody that reduces free IgE in circulation, decreasing mast cell and basophil reactivity non-specifically — it does not induce tolerance to any specific allergen. Allergy shots (SCIT) train the immune system to specifically tolerate identified allergens through regulatory T-cell expansion and IgG4 blocking antibody production. Xolair is a monthly or bimonthly subcutaneous injection; SCIT is a weekly-to-monthly injection program. Xolair was FDA-approved in February 2024 for food-allergy reaction prevention (OUtMATCH trial), and is also approved for chronic spontaneous urticaria and moderate-to-severe asthma. It is not a substitute for allergen-specific immunotherapy.
Why don't more patients use needle-free SLIT instead of SCIT?
Several factors limit SLIT adoption in the US despite its needle-free advantage. First, FDA-approved SLIT tablets cover only four allergen categories — grass, ragweed, and dust mite — leaving most multi-allergen patients without an approved needle-free option. Off-label compounded SLIT drops cover more allergens but are not FDA-approved as finished products and vary in quality between compounding pharmacies. Second, insurance coverage for off-label SLIT drops is inconsistent and often denied. Third, physician practice patterns favor SCIT in the US, partly due to historical familiarity and established CPT billing codes. Fourth, patient education about SLIT alternatives is limited. The Tkacz 2021 data showing 23.9% dropout before first injection suggests many patients who could benefit from SLIT never learn it is an option.
What is the difference between sublingual drops and allergy shots?
Allergy shots (SCIT) deliver allergen via subcutaneous injection — a 26G–27G needle in the upper outer arm — with a post-injection observation period. Sublingual drops deliver allergen under the tongue, absorbed through oral mucosal Langerhans-like dendritic cells. The delivery route changes the safety profile significantly: SLIT has a much lower systemic reaction risk, does not require a post-injection observation period, and can be taken daily at home. Both routes require 3–5 years for disease-modifying benefit. SCIT's evidence base is larger and older (since Noon 1911), with more allergens studied. SLIT's convenience allows much better adherence for patients who cannot commit to frequent injection visits. For patients who prefer the efficacy profile of SCIT but want to self-administer at home, Curex's at-home SCIT program — one weekly shot, $129/month — uses a USP <797>-compounded serum with a prescribed epinephrine auto-injector confirmed on hand and Zoom-supervised first and escalation doses.
Related Articles
Allergy Shot Vials: Color Code & Dilution Ladder | Curex
Allergy shot vials: red/yellow/blue/green/silver color code per Cox 2011 — but only 41% are actually color-coded. Read labels, not colors. Full guide.
Read moreAllergy Injections Guide: Schedule & Safety | Curex
Allergy injections (SCIT) mean 60-80+ visits over 3-5 years. Cochrane 51 RCTs: SMD -0.73. Learn what goes in the vial, the schedule, and real-world adherence data.
Read moreHow Do Allergy Shots Work? Immune Mechanism | Curex 2025
Allergy shots work through IgG4 blocking antibodies and regulatory T cells. Full science-backed explanation of the molecular cascade behind SCIT.
Read moreAllergy Shots Ingredients FAQ: Mercury, Blood, Latex | Curex
Is there mercury in allergy shots? Blood? Latex? mRNA? Each concern answered with citations. Modern US shots use phenol 0.4% and glycerin, not thimerosal.
Read moreCluster Allergy Shots: Schedule & Safety | Curex
Cluster allergy shots reach maintenance in 4–8 weeks vs 6 months. Schedule, the 3× higher per-injection reaction rate, and who qualifies (Tabar 2005).
Read moreAllergy Shot Chart: Build-Up Dose Table Guide | Curex
An allergy shot chart tracks dilution, volume, wheal, and dose adjustments. Cox 2011 build-up schedule. Color-code honesty: only 41% of vials are labeled.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.